$tr2['classname']

肺癌

$tr2['classname']

乳腺癌

$tr2['classname']

结直肠癌

$tr2['classname']

前列腺癌

$tr2['classname']

甲状腺癌

$tr2['classname']

宫颈癌

$tr2['classname']

胃癌

$tr2['classname']

肝癌

$tr2['classname']

胆囊癌

$tr2['classname']

卵巢癌

$tr2['classname']

食管癌

$tr2['classname']

胰腺癌

$tr2['classname']

膀胱癌

$tr2['classname']

淋巴瘤

$tr2['classname']

子宫内膜癌

$tr2['classname']

肾癌

$tr2['classname']

罕见肿瘤

首页 > TAG信息列表 > 输卵管癌

尼拉帕利|上市信息

卵巢癌一线治疗新药尼拉帕利(niraparib)在中国获批

氟唑帕利|上市信息

恒瑞医药PARP抑制剂氟唑帕利正式获批上市,治疗卵巢癌,输卵管癌或

贝伐珠单抗(普贝希)|上市信息

百奥泰/百济神州「贝伐珠单抗」生物类似药普贝希3项新适应症(卵巢

贝伐珠单抗(贝安汀)|上市信息

贝达药业贝伐珠单抗生物类似药贝安汀?获批新增适应症